# FDA 483 - Paramesh Banerji Life Sciences, LLC - September 24, 2021

Source: https://www.globalkeysolutions.net/records/483/paramesh-banerji-life-sciences-llc/7cbaa98d-1380-4a2b-9699-6d5285c47cdc

> FDA 483 for Paramesh Banerji Life Sciences, LLC on September 24, 2021. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Paramesh Banerji Life Sciences, LLC
- Inspection Date: 2021-09-24
- Product Type: drugs
- Office Name: New Jersey District Office
- Summary: An FDA inspection of Paramesh Banerji Life Sciences, LLC, a homeopathic drug manufacturer in North Brunswick, NJ, revealed significant deficiencies. The firm lacked a quality control unit, written procedures for critical processes, and appropriate temperature and humidity controls for drug product storage. This included a repeat observation regarding the absence of a quality control unit.

## Related Documents

- [483 - 2023-08-24](https://www.globalkeysolutions.net/records/483/paramesh-banerji-life-sciences-llc/d7ee693b-f6f9-4f5a-b5ad-e6662a4e7ce6)

## Related Officers

- [Ankur C. Patel](https://www.globalkeysolutions.net/people/ankur-c-patel/602c7d14-2c48-4929-a07b-6e4c235d7f13)
- [issuing_officer](https://www.globalkeysolutions.net/people/ko-min/767a6604-9a34-49c7-8462-c763c2689f61)

Company: https://www.globalkeysolutions.net/companies/paramesh-banerji-life-sciences-llc/8a5dcf24-e253-4116-a968-f9b1a890d15b

Office: https://www.globalkeysolutions.net/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248